Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05824559 |
| Title | ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MEI Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | United States | Details | |
| Mount Sinai Miami | Miami Beach | Florida | 33140 | United States | Details | |
| Johns Hopkins | Baltimore | Maryland | 21218 | United States | Details | |
| Rutgers University | New Brunswick | New Jersey | 08901 | United States | Details | |
| Mt Sinai New York | New York | New York | 10029 | United States | Details | |
| Vanderbilt -Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
| University of Utah | Salt Lake City | Utah | 84108 | United States | Details |